ClinicalTrials.Veeva

Menu

Pilot Study About Tamoxifen Therapy for Breast Cancer Patients

N

National Cancer Center (NCC)

Status

Unknown

Conditions

Breast Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT02094495
NCC 2014-0112-0001

Details and patient eligibility

About

The aim of this study are to to evaluate the knowledge and understanding on tamoxifen theraphy for breast cancer patients and examine the decision conflict scale and satisfaction with decision scale while making decision to take tamoxifen.

Full description

The knowlege questionnaire about tamoxifen was developed by the medication guides that provide for patients taking tamoxifen and hormone therapy for breast cancer fact sheet from National Cancaer Institute. Several experts in the field of breast cancer and gynecologic cancer are going to review and indicate the questionnaire.

Enrollment

300 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • The breast cancer patients who take tamoxifenExclusion Criteria:

Exclusion criteria

  • The patients who do not agree to participate in this study
  • The paitents who have trouble with understanding and reading Korean.

Trial design

300 participants in 1 patient group

breast cancer group
Description:
Taking tamoxifen

Trial contacts and locations

1

Loading...

Central trial contact

Eun Sook Lee, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems